Sort
78,016 grants matching “breast cancer”
FANCONI ANEMIA:GENOTYPE-PHENOTYPE CORRELATIONS
$760,303Elaine Ostrander · National Human Genome Research Institute · ZIA · FY2011 · HG
TARGETING A NOVEL LIPID KINASE COMPLEX THAT REGULATES MUTANT P53 STABILITY IN TRIPLE-NEGATIVE BREAST CANCER
$760,245University Of Wisconsin System · · FY2017 · Department of the Army
Hormonal Regulation of Breast Cancer
$760,199Jeffrey Rosen · Baylor College Of Medicine · R37 · FY2007 · CA
Genetic Epidemiology of Cancer
$760,199Joan E. Bailey-Wilson · National Human Genome Research Institute · ZIA · FY2013 · HG
Novel Markers for Disease Outcome in Breast Cancer
$759,873Stefan Ambs · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
EMPOWER Study: Promoting BC Screening in Women Who Survived Childhood Cancer
$759,828Kevin Charles Oeffinger · Duke University · R01 · FY2019 · CA
Streamlined Template Preparation for Advanced Sequencing Methods
$759,811Steven Jeffrey Gordon · Intelligent Bio-Systems, Inc. · R44 · FY2009 · HG
Exercise for Bone Health: Young Breast Cancer Survivors
$759,562Joan R Bloom · University Of California Berkeley · R01 · FY2009 · CA
Evaluation of an implantable microdevice for rapid cancer drug screening directly in T cell lymphoma patients
$759,496Cecilia Larocca · Brigham And Women'S Hospital · R37 · FY2020 · CA
P53 in BBD and Breast Cancer Risk: A Multicenter Cohort
$759,331Albert Einstein Col Of Med Yeshiva Univ · R01 · FY2004 · CA
Targeted degradation of RNAs by using small molecules
$759,311Matthew D Disney · University Of Florida · R01 · FY2025 · CA
Genes, Hormones &Environment in an Ovarian Cancer Model
$759,307Brigham And Women'S Hospital · R01 · FY2003 · CA
TARGETED INHIBITION OF LEUKEMIA INHIBITORY FACTORY (LIF)/LIFR AXIS FOR THE TREATMENT OF TRIPLE-NEGATIVE BREAST CANCER
$759,247The University Of Texas Health Science Center At San Antonio · · FY2018 · Defense Health Agency
Development of TGF-beta antagonists for cancer therapy
$758,999Lalage Wakefield · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
PET nanoreporter image-guided breast cancer therapy
$758,800Willem Mulder · Icahn School Of Medicine At Mount Sinai · R01 · FY2018 · CA
DRUG DISCOVERY OF BAX ACTIVATORS FOR THE TREATMENT OF BREAST CANCER
$758,753Louisiana State University Health Sciences Center New Orleans · · FY2017 · Department of the Army
An integrated microfluidic device for patient-derived micro-organospheres
$758,547Daniel Aaron Nelson · Xilis, Inc. · R44 · FY2025 · CA
Stromal contributions to breast carcinogenesis
$758,543Lusine Yaghjyan · University Of Florida · R01 · FY2023 · CA
Trametes Versicolor-Induced Immunopotentiation
$758,477Joel W Slaton · University Of Minnesota · U19 · FY2008 · AT
Metabolic Effects of Thyroid Hormone
$758,470New York University School Of Medicine · R01 · FY2005 · DK
Cancer Prevention & Control Training Program
$758,397Douglas C Heimburger · University Of Alabama At Birmingham · R25 · FY2008 · CA
Cancer Deep Phenotype Extraction from Electronic Medical Records
$758,275Rebecca S Crowley · University Of Pittsburgh At Pittsburgh · U24 · FY2015 · CA
SIRT3 is a genomically expressed mitochondrial TSG
$758,220David Gius · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Multimarker Risk Prediction in Cancer Therapy Cardiotoxicity
$758,005Bonnie Ky · University Of Pennsylvania · R01 · FY2016 · HL
Facilitating the Implementation of Population-wide Genomic Screening (FOCUS)
$757,994Caitlin Gloeckner Allen · Wake Forest University Health Sciences · R01 · FY2025 · HG